NCT06508190

Brief Summary

Research evaluating the impact of continuous positive airway pressure (CPAP) \& walking exercise on fatigue severity, liver enzymes and sleeping quality in patients with non-alcoholic fatty liver disease who also have obstructive sleep apnea. Forty patients are divided into two groups: twenty patients CPAP and other twenty patients for CPAP and walking program .

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 12, 2024

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

July 13, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 18, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

July 18, 2024

Status Verified

July 1, 2024

Enrollment Period

5 months

First QC Date

July 13, 2024

Last Update Submit

July 13, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Alanine tranaminase

    serum hepatic enzyme

    it will be measured after 12 weeks

Secondary Outcomes (6)

  • Asparatate transamianse

    it will be measured after 12 weeks

  • Body mass index

    it will be measured after 12 weeks

  • triglycerodes

    it will be assessed after 12 weeks

  • Pittsiburg sleeping quality index

    it will be assessed after 12 weeks

  • fatigue severity scale

    it will be assessed after 12 weeks

  • +1 more secondary outcomes

Study Arms (2)

continuous positive airway pressure therapy

ACTIVE COMPARATOR

The continuous positive airway pressure therapy equipment is used for 12 weeks, all patients in this group groups must utilize the CPAP machine for 4 hours each night.

Behavioral: continuous positive airway pressure

Free walking & continuous positive airway pressure therapy

EXPERIMENTAL

Each patient is required to walk 30 minutes, seven days a week for 12 weeks. \& The continuous positive airway pressure therapy equipment is used for 12 weeks, all patients in both groups must utilize the CPAP machine for 4 hours each night.

Behavioral: free walking exercise and continuous positive airway pressure

Interventions

continuous positive airway pressure therapy for a period of 12 weeks, all patients with in this group are required to utilize the CPAP machine for at least 4 hours each night

continuous positive airway pressure therapy

patients will receive continuous positive airway pressure therapy for a period of 12 weeks, all patients with in this group are required to utilize the CPAP machine for at least 4 hours each night. Also, patients will perform walking exercise for 30 mint, daily for 12 weeks

Free walking & continuous positive airway pressure therapy

Eligibility Criteria

Age40 Years - 65 Years
Sexall(Gender-based eligibility)
Gender Eligibility Detailsself-representation of gender identity.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The body mass index (BMI) \< 35 kg/m2.
  • obstructive sleep apnea patients with fatty liver

You may not qualify if:

  • liver transplantation , alcoholic fatty liver, antipsychotic medications, bariatric surgery; cardiac , renal problem , liver cancer ; pregnancy,orthopedic problems, systemic diseases, respiratory dysfunctions, neurological dysfunctions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahram canadian university

Giza, Egypt

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, ObstructiveNon-alcoholic Fatty Liver Disease

Interventions

Continuous Positive Airway Pressure

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesFatty LiverLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • El-Hadidy Hagar

    Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt

    PRINCIPAL INVESTIGATOR

Central Study Contacts

El-Hadidy Hagar, PHD

CONTACT

El-gohary Ola, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The authors of this clinical trial and patients do not provide the study outcome examiners with information regarding device therapy or free walking exercise.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Forty patients suffering from obstructive sleep apnea are divided into two groups: one for CPAP and the other for CPAP and free walking program.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

July 13, 2024

First Posted

July 18, 2024

Study Start

July 12, 2024

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

July 18, 2024

Record last verified: 2024-07

Locations